SCHEMBL4249360

SCHEMBL4249360

Nc1c(C(=O)O)cccc1-c1ccc(C(F)(F)F)cc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
EDNRB P24530 1/20 0.46
EDNRA P25101 1/20 0.46
CES2 O00748 2/20 0.46
CFTR P13569 1/20 0.43
EIF4E P06730 1/20 0.43
MPO P05164 3/20 0.42
G6PD P11413 1/20 0.41
CASP7 P55210 1/20 0.41
CASP6 P55212 1/20 0.41
TAS2R14 Q9NYV8 3/20 0.41
GRIK1 P39086 2/20 0.40
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40
GAA P10253 2/20 0.40
CYP2C9 P11712 2/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1358529 0.84 ALDH1A1 (0.49) ALDH1A1HPGDCFTRG6PDCASP7
SCHEMBL10588475 0.80 RORB (0.56) ALDH1A1KDM4EHPGDHSD17B10MPO
SCHEMBL30462474 0.77 TAS2R14 (0.55) ALDH1A1KDM4EHPGDCFTRG6PD
SCHEMBL9851131 0.76 G6PD (0.65) ALDH1A1KDM4EHPGDHSD17B10G6PD
SCHEMBL158167 0.75 G6PD (0.55) ALDH1A1KDM4EHPGDHSD17B10CFTR
SCHEMBL424263 0.75 CES2 (0.78) ALDH1A1KDM4EHPGDHSD17B10CES2
SCHEMBL30462467 0.74 TAS2R14 (0.43) ALDH1A1KDM4EHPGDCFTRG6PD
SCHEMBL4251283 0.74 KMO (0.46) CFTRG6PDCASP7CASP6ALOX5AP
Hydrochloric Acid SCHEMBL11631331 0.74 G6PD (0.53) ALDH1A1KDM4EHPGDHSD17B10CFTR
SCHEMBL17744802 0.73 G6PD (0.61) ALDH1A1KDM4EHPGDHSD17B10G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131527-A1 NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-05-21 US claimed
US-20090131527-A1 NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131527-A1 NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME CLIC1, ASIC1, CLIC4 ALDH1A1 1179/4885KDM4E 3594/4885HPGD 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.